| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $191K | -94.8% | -52.4% |
| Cost of Revenue | $584K | — | +184.9% |
| Gross Profit | -$393K | -148.8% | -300.5% |
| R&D Expense | $249K | — | -44.3% |
| SG&A Expense | $1.6M | +0.4% | -18.4% |
| Operating Income | -$2.3M | — | -1.0% |
| Net Income | -$2.2M | -604.2% | -5.5% |
| EPS (Basic) | -$0.39 | -550.0% | -875.0% |
| EPS (Diluted) | -$0.39 | -550.0% | -875.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.7M | -15.7% | -39.9% |
| Accounts Receivable | $171K | -87.4% | +26.7% |
| Current Assets | $8.8M | -21.8% | -34.9% |
| Total Assets | $9.8M | -19.3% | -32.3% |
| Current Liabilities | $2.2M | -16.0% | -9.4% |
| Total Liabilities | $2.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.3M | — | -21.3% |
| Capital Expenditures | $4K | — | +0.0% |
| Investing Cash Flow | -$64K | — | -56.1% |
| Financing Cash Flow | -$32K | — | -88.2% |
| Free Cash Flow | -$1.4M | — | -21.3% |
| -11.3% |
| Stockholders' Equity | $7.6M | -20.0% | -36.7% |